Patlytics offers an end-to-end AI platform purpose-built for patent workflows, covering invention harvesting, application drafting, infringement analysis, invalidity contentions, and portfolio management. The company reports measurable customer impacts such as an 80% reduction in project time, more than $30,000 saved per claim chart, and up to 15 hours recovered per patent application. Patlytics is trusted by over 40% of Am Law 100 firms and a number of corporate IP teams and ranked practices. Following the $40 million Series B, bringing total funding to about $65 million, the company plans to develop an AI-native collaboration suite, domain-specific autonomous AI Agents, and deeper chem-bio capabilities. Patlytics is expanding globally with a new London office and a recently appointed Head of EMEA. The company is headquartered in New York.

Total raised

$59M

Funding rounds

3

Latest round

Series B

Latest activity

Apr 2026